Abnormality of the foot musculature
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Absent reflex
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Acute lymphocytic leukemia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mutations in DNM2 are common in early T-cell precursor acute lymphoblastic leukemia.
|
27885263 |
2016 |
Adenovirus Infections
|
0.010 |
Biomarker
|
group |
BEFREE |
Ionizing radiation-induced adenovirus infection is mediated by Dynamin 2.
|
15994918 |
2005 |
Adult Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Dynamin 2 inhibition therefore represents a novel approach for stem cell-directed Glioblastoma therapy.
|
30907150 |
2019 |
Akinesia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We report the first homozygous mutation in the DNM2 protein p.Phe379Val, in three consanguineous patients with a lethal congenital syndrome associating akinesia, joint contractures, hypotonia, skeletal abnormalities, and brain and retinal hemorrhages.
|
23092955 |
2013 |
Alzheimer Disease, Late Onset
|
0.020 |
Biomarker
|
disease |
BEFREE |
Dynamin 2 gene is a novel susceptibility gene for late-onset Alzheimer disease in non-APOE-epsilon4 carriers.
|
18236001 |
2008 |
Alzheimer Disease, Late Onset
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
These data suggest that DNM2 expression is reduced in LOAD, which results in the accumulation of APP in lipid raft-rich plasma membranes.
|
19126407 |
2009 |
Alzheimer's Disease
|
0.030 |
AlteredExpression
|
disease |
LHGDN |
Decrease of dynamin 2 levels in late-onset Alzheimer's disease alters Abeta metabolism.
|
19126407 |
2009 |
Alzheimer's Disease
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
It has been shown that beta amyloid, deposited in the AD brain, interacts with dynamin 1 and that the dynamin 2 (DNM2) gene homologous to the dynamin 1 gene is encoded at chromosome 19p13.2 where a susceptibility locus has been detected by linkage analysis.
|
18236001 |
2008 |
Alzheimer's Disease
|
0.030 |
Biomarker
|
disease |
LHGDN |
It has been shown that beta amyloid, deposited in the AD brain, interacts with dynamin 1 and that the dynamin 2 (DNM2) gene homologous to the dynamin 1 gene is encoded at chromosome 19p13.2 where a susceptibility locus has been detected by linkage analysis.
|
18236001 |
2008 |
Alzheimer's Disease
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Furthermore, single nucleotide polymorphisms located in the dynamin-2 gene have been associated with sporadic Alzheimer's disease.
|
24102355 |
2014 |
Areflexia of lower limbs
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Asphyxia Neonatorum
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Autosomal Dominant Myotubular Myopathy
|
0.300 |
Biomarker
|
disease |
CTD_human |
Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene.
|
17376685 |
2007 |
Autosomal Recessive Centronuclear Myopathy
|
0.310 |
Biomarker
|
disease |
CTD_human |
Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene.
|
17376685 |
2007 |
Autosomal Recessive Centronuclear Myopathy
|
0.310 |
Biomarker
|
disease |
BEFREE |
Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy.
|
17676042 |
2007 |
Axonal degeneration
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Axonal neuropathy
|
0.020 |
Biomarker
|
disease |
BEFREE |
The histopathological findings indicate the coexistence of typical axonal neuropathy and chronic myopathy in DNM2-related neuromuscular diseases.
|
28971531 |
2018 |
Axonal neuropathy
|
0.020 |
Biomarker
|
disease |
BEFREE |
Symptoms in DNM2-CNM included bilateral ptosis (n = 3), paresis of the external ocular muscles (n = 2), axonal neuropathy (n = 4), restrictive ventilatory involvement (n = 5), and contractures (n = 5), including muscular torticollis (n = 1) and masticatory muscles (n = 2).
|
21221624 |
2011 |
Bilateral cataracts (disorder)
|
0.020 |
Biomarker
|
disease |
BEFREE |
Whilst DNM2-related CMT may feature non-neurological findings including cataracts, this has not been reported in DNM2-related centronuclear myopathy.
|
19932620 |
2010 |
Bilateral cataracts (disorder)
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
We conclude that dynamin 2 mutations should be screened in the autosomal dominant Charcot-Marie-Tooth neuropathy families with intermediate or axonal NCV, and in patients with a classical mild to moderately severe Charcot-Marie-Tooth phenotype, especially when Charcot-Marie-Tooth is associated with neutropaenia or cataracts.
|
19502294 |
2009 |
Bladder Neoplasm
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Caveolin-1 and dynamin-2 overexpression is associated with the progression of bladder cancer.
|
31289491 |
2019 |
Blepharoptosis
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Blepharoptosis
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Symptoms in DNM2-CNM included bilateral ptosis (n = 3), paresis of the external ocular muscles (n = 2), axonal neuropathy (n = 4), restrictive ventilatory involvement (n = 5), and contractures (n = 5), including muscular torticollis (n = 1) and masticatory muscles (n = 2).
|
21221624 |
2011 |